Marcelo DiCarli, MD, and Rob Beanlands, MD, discussed the long-term value of investing in the development and implementation of AI technologies. 

As the world grapples with the potential downsides of generative AI, a global group of healthcare researchers is warning of health perils that could emanate from well beyond clinical settings.

The National Science Foundation (NSF) is setting up seven new institutes for studying foundational AI. Two of the initiatives have healthcare as a prime focus.

Researchers analyzed 266 safety events reported to the FDA’s Manufacturer and User Facility Device Experience (“Maude”) program.

Every industry on earth is buzzing over the promise and potential of ChatGPT and similarly sharp AI models, whether “large language” or another generative form. Healthcare is no exception. But shouldn’t it be?

Radiologist David Gruen, MD, discusses some of the overarching themes from the Healthcare Information Management Systems Society's annual meeting.

Fresh off its success using AI to develop a blockbuster COVID vaccine, up-and-coming biotech player Moderna (founded 2010) has won the confidence of 112-year-old Big Blue as a strategic partner.

If great power obligates its wielder to exercise great responsibility, those advancing AI in healthcare are up to their necks in duty.